Literature DB >> 6231099

Hematoporphyrin derivative-induced photosensitivity of mitochondrial succinate dehydrogenase and selected cytosolic enzymes of R3230AC mammary adenocarcinomas of rats.

R Hilf, D B Smail, R S Murant, P B Leakey, S L Gibson.   

Abstract

The photosensitizing activity of hematoporphyrin derivative (HPD) was investigated by studying selected enzymes localized to mitochondria and cytosol of R3230AC mammary adenocarcinomas. Experiments in vitro demonstrated that mitochondrial succinate dehydrogenase was inhibited in a drug dose- and light exposure time-related manner; at 7.0 micrograms of HPD per ml or higher, enzyme activity was inhibited greater than 50% after 15 min of photoradiation. The three cytosol enzymes studied under the same conditions in vitro demonstrated different photosensitivities. Pyruvate kinase activity was significantly inhibited in a dose- and time-related fashion, whereas lactate dehydrogenase was inhibited to a lesser extent, and glucose phosphate isomerase activity was inhibited only at the highest dose (70 micrograms of HPD per ml) used. The time-course of these responses was examined with an in vivo-in vitro protocol, consisting of photoradiation of mitochondria and cytosol prepared from tumors obtained at various times (up to 1 week) after a single injection of HPD (80 mg/kg). Pyruvate kinase activity was markedly inhibited at early times returning to initial levels by 48 hr; neither lactate dehydrogenase nor glucose phosphate isomerase was inhibited by this treatment. Mitochondrial succinate dehydrogenase and cytochrome c oxidase activities displayed significant photoradiation-induced inhibitions, with greatest inhibition occurring between 24 and 96 hr after injection of HPD; at 1 week, succinate dehydrogenase activity had returned to its initial level, but cytochrome c oxidase activity remained significantly inhibited. These data suggest that HPD-induced photosensitization of mitochondria may be an important site of action contributing to tumor cell cytotoxicity and regression as a result of photoradiation therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231099

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Interaction of porphyrins with heme proteins--a brief review.

Authors:  Abhay Sankar Chakraborti
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

2.  Response of human endometrium and ovarian carcinoma cell-lines to photodynamic therapy.

Authors:  G H Raab; A F Schneider; W Eiermann; H Gottschalk-Deponte; R Baumgartner; W Beyer
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

3.  Photodynamic therapy for cancer.

Authors:  A M Abulafi; N S Williams
Journal:  BMJ       Date:  1992-03-07

Review 4.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 5.  Mitochondria are targets of photodynamic therapy.

Authors:  Russell Hilf
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 2.945

6.  Morphologic studies of bladder tumors treated with hematoporphyrin derivative photochemotherapy.

Authors:  J E Klaunig; S H Selman; J R Shulok; P J Schafer; S L Britton; P J Goldblatt
Journal:  Am J Pathol       Date:  1985-05       Impact factor: 4.307

7.  In vitro photosensitization of tumour cell enzymes by photofrin II administered in vivo.

Authors:  S L Gibson; R S Murant; M D Chazen; M E Kelly; R Hilf
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

8.  Evaluation of the effects of photodynamic therapy with phosphorus 31 magnetic resonance spectroscopy.

Authors:  M Nishiwaki; Y Fujise; T O Yoshida; E Matsuzawa; Y Nishiwaki
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

9.  Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy.

Authors:  T L Ceckler; S L Gibson; S D Kennedy; R Hill; R G Bryant
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

10.  Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies.

Authors:  C Perotti; H Fukuda; G DiVenosa; A J MacRobert; A Batlle; A Casas
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.